# Prevention of Relapse & Recurrence of Bipolar Depression

> **NCT00961961** · PHASE4 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 177 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lithium / Fluoxetine
- **DRUG:** Lithium / Placebo

## Key facts

- **NCT ID:** NCT00961961
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-01
- **Primary completion:** 2016-09-01
- **Final completion:** 2016-09-01
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2020-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00961961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00961961, "Prevention of Relapse & Recurrence of Bipolar Depression". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00961961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*